Operating Lease, Liability of VBI Vaccines Inc/BC from 31 Dec 2018 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
VBI Vaccines Inc/BC quarterly Operating Lease, Liability in USD history and change rate from 31 Dec 2018 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Operating Lease, Liability for the quarter ending 31 Mar 2024 was $1,967,000, a 35% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,967,000 -$1,045,000 -35% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $2,271,000 -$1,066,000 -32% 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q3 2023 $2,420,000 -$1,065,000 -31% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,725,000 -$673,000 -20% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $3,012,000 -$847,000 -22% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $3,337,000 -$18,000 -0.54% 31 Dec 2022 10-K 13 Mar 2023 2022 FY
Q3 2022 $3,485,000 +$2,970,000 +577% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $3,398,000 +$2,268,000 +201% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $3,859,000 +$2,512,000 +186% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,355,000 +$1,792,000 +115% 31 Dec 2021 10-K 07 Mar 2022 2021 FY
Q3 2021 $515,000 -$1,131,000 -69% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $1,130,000 -$699,000 -38% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $1,347,000 +$130,000 +11% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $1,563,000 +$104,000 +7.1% 31 Dec 2020 10-K 02 Mar 2021 2020 FY
Q3 2020 $1,646,000 +$14,000 +0.86% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $1,829,000 +$264,000 +17% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $1,217,000 -$502,000 -29% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,459,000 -$161,000 -9.9% 31 Dec 2019 10-K 05 Mar 2020 2019 FY
Q3 2019 $1,632,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $1,565,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $1,719,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $1,620,000 31 Dec 2018 10-K 25 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.